Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Exploring Epigenetic Aging and Cardiovascular Disease Risk
Clinical Breakthroughs

Exploring Epigenetic Aging and Cardiovascular Disease Risk

By Melissa RohmanSep 15, 2021
Share
Facebook Twitter Email
Donald-Lloyd Jones, MD, ScM, the Eileen M. Foell Professor and chair of Department of Preventive Medicine, was senior author of the study published in Circulation Research.

Epigenetic aging — derived from the molecular mechanisms governing gene regulation — could serve as a promising biomarker for measuring long-term cardiovascular health and disease risk, according to a Northwestern Medicine study published in the journal Circulation Research.

Epigenetic aging represents a novel measure of biological age — or how old the body is physiologically, independent of chronological age — with potential significance for age-related chronic diseases. In terms of cardiovascular health and disease specifically, identifying the molecular mechanisms that promote cardiovascular disease risk factors could improve targeted therapies, disease detection and prevention efforts for patients, according to the authors.

“This is the information patients are often interested in: that their biological age is actually going faster than their chronological age. The biological age is the miles, the chronological age is the years, and you want to minimize the miles and maximize the years,” said Donald-Lloyd Jones, MD, ScM, the Eileen M. Foell Professor, chair of Department of Preventive Medicine and co-senior author of the study.

To identify associations between epigenetic aging acceleration and cardiovascular health, the investigators analyzed epigenetic screening data from more than 3,000 participants enrolled in The Coronary Artery Risk Development in Young Adults (CARDIA) study and the Framingham Heart Study, both longitudinal, population-based studies examining cardiovascular disease and risk.

Using this data, the team identified associations between participants’ cardiovascular health scores and their GrimAge acceleration, a measure of the difference between one’s biological age and one’s chronological age at a given time. Participants’ cardiovascular health was measured using their scores from the American Heart Association’s “Life’s Simple 7”, which measures cardiovascular health based on seven risk factors (diet, smoking status, physical activity, BMI, blood pressure, cholesterol and blood glucose) and their clinical cardiovascular health scores, a sub-score measuring BMI, blood pressure, cholesterol and blood glucose.

Brian Joyce, PhD, research assistant professor of Preventive Medicine and lead author of the study.

“CARDIA is ideal here because we met these people when they were as young as age 18 and we followed them now for up to 35 years. By being able to integrate their early life information and link it to midlife GrimAge, we can start to understand some of the mechanisms by which we age biologically or molecularly,” said Lloyd-Jones, who is principal investigator of CARDIA’s Chicago field center at Northwestern Memorial Hospital.

From the data, the investigators found that for every point higher in cardiovascular health a participant had, their biological age was 0.67 years, or about eight months, younger than their chronological age — demonstrating that their biological age was accelerating more slowly over time than their chronological age.

“We hypothesized that this association would be there, but the magnitude of the association was certainly much bigger than we would ever have anticipated,” said Lloyd-Jones.

The findings demonstrate that faster GrimAge acceleration is associated with loss of cardiovascular health from as early as young adulthood, highlighting the role of epigenetic mechanisms in linking age-related cardiovascular health loss and cardiovascular disease.

“These are the kinds of markers that can theoretically capture health effects from a very wide variety of sources that just the simple seven markers. There’s a whole ream of research on social determinants of health that we’re just barely scratching the surface with,” said Brian Joyce, PhD, research assistant professor of Preventive Medicine and lead author of the study.

Lifang Hou, MD, PhD, chief of Cancer Epidemiology and Prevention in the Department of Preventive Medicine, was co-senior author of the study. Coauthors include Tao Gao, MD, research assistant professor of Preventive Medicine in the Division of Cancer Epidemiology and Prevention; Yinan Zheng, ’17 PhD, research assistant professor of Preventive Medicine in the Division of Cancer Epidemiology and Prevention; Norrina Allen, PhD, Associate Professor of Preventive Medicine in the Division of Epidemiology and of Pediatrics; Hongyan Ning, MS, Research Assistant Professor of Preventive Medicine in the Division of Biostatistics; Kiang Liu, PhD, professor emeritus of Preventive Medicine in the Division of Epidemiology; and Philip Greenland, MD, the Harry W. Dingman Professor of Cardiology.

This work was supported by American Heart Association grants 17SFRN33700278, 14SFRN20790000 and R21 AG063370, and the American Heart Association Career Development Award 19CDA34630050.

Cardiology Epigenetics Preventive Medicine Research
Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Comments are closed.

Latest News

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.